SEO URLwww.firestrike.ai/deals/day-one-biopharma-servier-pharmaceuticals-llc-acquisition-2026
acquisitionAnnounced · Mar 6, 2026Professional, Scientific, and Technical Services (541)Source · CredibleArticle · Factual
Servier Pharmaceuticals LLC acquires Day One Biopharma
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
$2.3B
Target
Day One Biopharma
NASDAQ: DAWN · Brisbane, California
Acquirer
Servier Pharmaceuticals LLC
Full Acquisition
Status
Pending
Servier Pharmaceuticals LLC agreed to acquire Day One Biopharma. Reported deal value: $2.3B. Status: Pending. Sector: Not specified. Target headquarters context: Brisbane, California, United States.
This page summarizes publicly available information about the transaction as of 2026-03-06. Figures and status may change as filings and press coverage update.
Servier Pharmaceuticals LLC entered into a definitive agreement to acquire Day One Biopharmaceuticals , Inc. for $2.3 billion on March 6, 2026
Deal timeline
Announced
Mar 6, 2026 · uk.marketscreener.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Professional, Scientific, and Technical Services (541) with a reported deal value of $2.3B. Figures and status may change as sources update.
Sources: uk.marketscreener.com · Primary article · FireStrike proprietary index